Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
iSpecimen (ISPC)
NASDAQ:ISPC
Holding ISPC?
Track your performance easily
Earnings Data
Report Date
Mar 12, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -32.43%
|Next Earnings Date:Mar 12, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and significant operational improvements, particularly with the successful Next Day Quote program. However, challenges such as increased costs and a decrease in specimen count were noted. Despite some challenges, the overall tone was optimistic about future growth.Company Guidance
During the second quarter of 2024, iSpecimen reported revenue of approximately $2.9 million, a 76% increase from $1.6 million in the same period the previous year. This growth was driven by a 26% rise in specimen count, from 4,682 to 5,918, and a 39% increase in the average selling price per specimen, from $347 to $484. The company's Next Day Quote program significantly contributed to these results, with 44% of quotes provided under this program, up from 38% in Q4 2023. Additionally, 58% of these quotes converted to purchase orders in the first half of 2024. iSpecimen also achieved a 59% reduction in cash burn from $7.1 million in H1 2023 to $2.9 million in H1 2024. They focused on enhancing supplier quality, reducing their network from 240 to 105 suppliers while improving capabilities. Cost of revenue increased by 67% to $1.4 million, aligned with the growth in specimen count and average cost per specimen. The company reduced its cash spend for technology by 64%, from $1.5 million to $541,000, for Q2 2024. Overall, iSpecimen continues to refine operations and expects sustained success in the latter half of 2024.Significant Revenue Growth
Generated revenues of approximately $2.9 million in Q2 2024, a 76% increase compared to $1.6 million for the same period in the prior year.
Reduction in Cash Burn
Reduced cash burn from approximately $7.1 million in the first half of 2023 to $2.9 million for the first half of 2024, a 59% decrease.
Next Day Quote Program Success
The Next Day Quote program has been successful, with 58% of quotes converting to purchase orders in the first half of 2024.
Improvement in Supplier Network
Reduced the supplier network from 240 in 2023 to 105, while improving capabilities and quality.
New Leadership in Sales
Appointed Brielan Smiechowski as Senior Vice President of Sales and Business Development, bringing over 15 years of experience.
---
ISPC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ISPC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $4.44 | $4.94 | +11.26% |
| Aug 06, 2024 | $4.77 | $5.00 | +4.82% |
| May 07, 2024 | $5.52 | $5.95 | +7.79% |
| Mar 13, 2024 | $8.20 | $9.20 | +12.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does iSpecimen (ISPC) report earnings?
iSpecimen (ISPC) is schdueled to report earning on Mar 12, 2025, TBA Not Confirmed.
What is iSpecimen (ISPC) earnings time?
iSpecimen (ISPC) earnings time is at Mar 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ISPC EPS forecast?
Currently, no data Available
---